Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: Phase I studies

European Journal of Endocrinology

Volumn 140, Issue 5, 1999, Pages 414-419

  Behre, H M ^b   Abshagen, K ^b   Oettel, M ^a   Hubler D ^a   Nieschlag, E ^b  

^a BAYER PHARMA AG   (Germany)

^b INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASTOR OIL; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; VEGETABLE OIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HALF LIFE; GLUTEUS MAXIMUS MUSCLE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; BODY WEIGHT; ESTRADIOL; GONADOTROPINS; HORMONES; HUMANS; HYPOGONADISM; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE CONGENERS;

EID: 0033014486     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400414     Document Type: Article

References (18)

1. Nieschlag E & Behre HM. Pharmacology and clinical uses of testosterone. In Testosterone - Action, Deficiency, Substitution, edn 2, pp 293-328. Eds E Nieschlag & HM Behre. Berlin, Heidelberg, New York: Springer-Verlag, 1998.
2. Atkinson LE, Chang Y-L & Snyder JP. Long-term experience with testosterone replacement through scrotal skin. In Testosterone - Action, Deficiency, Substitution, edn 2, pp 364-388. Eds E Nieschlag & HM Behre. Berlin, Heidelberg, New York: Springer-Verlag, 1998.
3. Meikle AW. A permeation-enhanced non-scrotal testosterone transdermal system for the treatment of male hypogonadism. In Testosterone - Action, Deficiency, Substitution, edn 2, pp 389-422. Eds E Nieschlag & HM Behre. Berlin, Heidelberg, New York: Springer-Verlag, 1998.
4. Behre HM, von Eckardstein S, Kliesch S & Nieschlag E. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over seven to ten years. Clinical Endocrinology 1999 (In Press).
5. Nieschlag E. If testosterone, which testosterone? Which androgen regimen should be used for supplementation in older men? Formulation, dosing, and monitoring issues. Therapeutic controversy VII. Journal of Clinical Endocrinology and Metabolism 1998 83 3443-3445.
6. Behre HM & Nieschlag E. Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester. Journal of Clinical Endocrinology and Metabolism 1992 75 1204-1210.
7. Wang LZ. The therapeutic effect of domestically produced testosterone undecanoate in Klinefelter's syndrome. New Drugs and Markets 1991 8 28-32.
8. Partsch C-J, Weinbauer GF, Fang R & Nieschlag E. Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthate. European journal of Endocrinology 1995 132 514-519.
9. Gibaldi M & Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1992.
10. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertility and Sterility 1996 65 821-829.
11. Behre HM & Nieschlag E. 1998 Comparative pharmacokinetics of testosterone esters. In Testosterone - Action, Deficiency, Substitution, edn 2, pp 329-348. Eds E Nieschlag & HM Behre. Berlin, Heidelberg, New York: Springer-Verlag, 1998.
12. Schulte-Beerbühl M & Nieschlag E. Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertility and Sterility 1980 33 201-203.
13. Schürmeyer T & Nieschlag E. Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men. International Journal of Andrology 1984 7 181-187.
14. Gooren LJG. A ten year safety study of the oral androgen testosterone-undecanoate. Journal of Andrology 1994 15 212-215.
15. Zhang GY, Gu YQ, Wang XH, Cui YG & Bremner WJ. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Journal of Andrology 1998 19 761-768.
16. Minto CF, Howe C, Wishart S, Conway AJ & Handelsman DJ. Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. Journal of Pharmacology and Experimental Therapeutics 1997 281 93-102.
17. Gerrity M, Freund M, Peterson RN & Falvo RE. The physiologic effects of testosterone in hydrogenated soybean oil vehicle as compared with free testosterone, testosterone propionate, and testosterone enanthate in a conventional oil vehicle. Journal of Andrology 1982 3 221-226.
18. Nieschlag E, Cüppers HJ, Wiegelmann W & Wickings EJ. Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men. Hormone Research 1976 7 138-145.